Carles-Kinch; Kelly

Patent Applications and Registrations

Patent applications and USPTO patent grants for Carles-Kinch; Kelly.The latest application filed is for "modulators of epha2 and ephrina1 for the treatment of fibrosis-related disease".

Company Profile

0.3.16

Carles-Kinch; Kelly - Laytonsville MD
Carles-Kinch; Kelly - Laytsonville MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modulators Of EphA2 And Ephrina1 For The Treatment Of Fibrosis-Related Disease App 20120121582 - Kinch; Michael S. ; et al.	2012-05-17
EphA2 AGONISTIC MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF App 20100298545 - Kinch; Michael S. ; et al.	2010-11-25
Epha2 Monoclonal Antibodies And Methods Of Use Thereof App 20100278838 - Kinch; Michael S. ; et al.	2010-11-04
Modulators of EphA2 and Ephrin-A1 for the treatment of fibrosis-related disease App 20100260749 - Kinch; Michael S. ; et al.	2010-10-14
USE OF EphA4 AND MODULATOR OF EphA4 FOR DIAGNOSIS, TREATMENT AND PREVENTION OF CANCER App 20100166657 - Kinch; Michael S. ; et al.	2010-07-01
Epha2 Agonistic Monoclonal Antibodies And Methods Of Use Thereof App 20100143345 - Kinch; Michael S. ; et al.	2010-06-10
EphA4 Antibodies Grant 7,604,799 - Kinch , et al. October 20, 2	2009-10-20
EphA2 monoclonal antibodies and methods of making and using same Grant 7,402,298 - Kinch , et al. July 22, 2	2008-07-22
EpA2 monoclonal antibodies and methods of use thereof App 20070166314 - Kinch; Michael S. ; et al.	2007-07-19
EphA2 agonistic monoclonal antibodies and methods of use thereof App 20070134254 - Kinch; Michael S. ; et al.	2007-06-14
EphA2 agonistic monoclonal antibodies and methods of use thereof App 20070086943 - Kinch; Michael S. ; et al.	2007-04-19
EphA2 monoclonal antibodies and methods of making and using same Grant 7,101,976 - Kilpatrick , et al. September 5, 2	2006-09-05
Use of modulators of EphA2 and EphrinA1 for the treatment and prevention of infections App 20060121043 - Kinch; Michael S. ; et al.	2006-06-08
Modulation of antibody specificity by tailoring the affinity to cognate antigens App 20060121042 - Dall'Acqua; William ; et al.	2006-06-08
Modulators of EphA2 and EphrinA1 for the treatment of fibrosis-related disease App 20060122138 - Kinch; Michael S. ; et al.	2006-06-08
EphA2 agonistic monoclonal antibodies and methods of use thereof App 20050152899 - Kinch, Michael S. ; et al.	2005-07-14
Use of EphA4 and modulator of EphA4 for diagnosis, treatment and prevention of cancer App 20050013819 - Kinch, Michael S. ; et al.	2005-01-20
EphA2 agonistic monoclonal antibodies and methods of use thereof App 20040091486 - Kinch, Michael S. ; et al.	2004-05-13
EphA2 monoclonal antibodies and methods of use thereof App 20040028685 - Kinch, Michael S. ; et al.	2004-02-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.